News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Accelerated Biosciences and Spanios Announce Partnership to Improve Therapeutic Approaches for Solid Tumor Cancers
Friday, May 17, 2024Spanios a company known for its unique D tumoroid platforms used to validate solid tumor therapies has announced a new partnership with Accelerated Biosciences Accelerated Biosciences
Aulos Bioscience Collaborates with Merck KGaA, Darmstadt, Germany for Joint Clinical Trial on Bavencio® and AU-007 Combination
Thursday, May 16, 2024Aulos Bioscience a company in immunooncology striving to transform cancer treatment with innovative IL therapeutics has announced a significant collaboration with Ares Trading SA a Swiss subsidiary
Verismo Therapeutics Obtains FDA Clearance for SynKIR™-310 in Relapsed/Refractory B-cell NHL
Wednesday, May 15, 2024Verismo Therapeutics has received approval from the US Food and Drug Administration to proceed with the Phase clinical trial of SynKIR for NHL This trial named CELESTIAL will evaluate the safety
FogPharma and ARTBIO Announce Partnership for the Development of Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies in Cancer Treatment
Wednesday, May 15, 2024FogPharma and ARTBIO Inc are collaborating to develop advanced therapies for various cancers FogPharma renowned for its innovative Helicon peptide platform and ARTBIO
Walden Biosciences Announces Collaboration with Leading Genetic Epidemiologist to Investigate suPAR's Causal Role in Chronic Kidney Disease
Tuesday, May 14, 2024Walden Biosciences Inc a biotechnology company focused on developing therapies for kidney disease has partnered with the Primula Group to utilize genetic data from individuals with chronic kidney disease
TriLink BioTechnologies Partners with Johns Hopkins University to Establish New RNA Innovation Hub
Tuesday, May 14, 2024TriLink BioTechnologies a division of Maravai LifeSciences and a leading global provider of life science reagents and services has announced a collaboration with Johns Hopkins University to accelerate
Ajax Therapeutics Receives FDA Approval for AJ1-11095 IND Application, a Novel Type II JAK2 Inhibitor, for Myelofibrosis Treatment
Tuesday, May 14, 2024Ajax Therapeutics Inc a biopharmaceutical company focused on developing nextgeneration JAK inhibitors for patients with myeloproliferative neoplasms has announced the clearance
Macomics and IFOM Announce Collaboration on Macrophage Research in Oncology
Monday, May 13, 2024Macomics Ltd a leader in macrophage drug discovery has announced a significant scientific collaboration with Prof Massimiliano Pagani from IFOM the AIRC Institute of Molecular Oncology
Arecor and Medtronic Diabetes Collaborate on Novel Thermostable Insulin for Implantable Pump Administration
Friday, May 10, 2024Arecor Therapeutics plc a biopharmaceutical company focused on advancing therapies for healthier lives has entered a research collaboration with Medtronic plc a global leader in healthcare technology
Dyno Therapeutics Partners with NVIDIA AI to Enhance Development of High-Performance Biological Sequences
Friday, May 10, 2024Dyno Therapeutics has recently announced an exciting collaboration with NVIDIA aimed at leveraging Dynos cuttingedge artificial intelligence and in vivo experimentation prowess alongside NVIDIAs
